Inhibrx Biosciences, Inc

INBXNASDAQ · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

14.7M

on 2026-06-30, from 14.5M on 2024-06-30 10-Q ↗

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

4 of its filings are not read yet.

Warrants

2.00M

Warrants of every class as tagged in the XBRL facts on 2025-12-31. 10-K ↗

Cash

4 quarters

$133.3M on 2026-06-30 ÷ $33.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 17 of its filings are not read yet.

Also on file: up to $500.0M notes agreed 2026-07-15 8-K ↗